XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Schedule of reconciliation of cash, cash equivalents and restricted cash
   June 30, 2022   December 31, 2021   June 30, 2021   December 31, 2020 
Cash and cash equivalents  $16,586,577   $36,080,392   $31,182,385   $13,360,463 
Restricted cash   441,320    551,794    551,260    746,792 
Total cash and cash equivalents and restricted cash in the condensed consolidated statements of cash flows  $17,027,897   $36,632,186   $31,733,645   $14,107,255 

 

Schedule of inventories
   June 30, 2022   December 31, 2021 
Raw materials and supplies  $884,474   $866,963 
Work-in-process   48,680    100,801 
Finished goods   3,756,404    3,744,029 
Total  $4,689,558   $4,711,793 

 

Schedule of finite-lived and indefinite-lived intangible assets
          

 

 

June 30, 2022

  

 

December 31, 2021

 
   Subsidiary   Cost  

Accumulated

Amortization

   Effect of Foreign Exchange Rates   Net Balance  

Accumulated

Amortization

   Effect of Foreign Exchange Rates   Net Balance 
Trademarks and tradenames   Curetis   $1,768,000   $(373,698)  $(107,132)  $1,287,170   (316,930)  $43,015   $1,494,085 
Distributor relationships   Curetis    2,362,000    (332,838)   (143,124)   1,886,038    (282,277)   57,465    2,137,188 
A50 - Developed technology   Curetis    349,000    (105,393)   (21,147)   222,460    (89,384)   8,492    268,108 
Ares - Developed technology   Curetis    5,333,000    (805,142)   (323,155)   4,204,703    (682,833)   129,745    4,779,912 
A30 - In-Process Research & Development   Curetis    5,706,000    —      (337,156)   5,368,844    —      144,916    5,850,916 
        $15,518,000   $(1,617,071)  $(931,714)  $12,969,215   $(1,371,424)  $383,633   $14,530,209 

 

Schedule of estimated useful lives of identifiable intangible assets
   Estimated Useful Life
Trademarks and tradenames  10 years
Customer/distributor relationships  15 years
A50 – Developed technology  7 years
Ares – Developed technology  14 years
A30 – Acquired in-process research & development  Indefinite

 

Schedule of expected amortization of intangible assets
Year Ending December 31,     
 2022 (Six months)   $359,349 
 2023    718,697 
 2024    718,697 
 2025    718,697 
 2026    718,697 
 2027    683,530 
 Thereafter    3,682,704 
 Total   $7,600,371 

 

Schedule of changes in carrying amount of goodwill
Balance as of December 31, 2021  $7,453,007 
Changes in currency translation   (568,092)
Balance as of June 30, 2022  $6,884,915